Document Type : Original Article


Department of Biology, Qom Branch, Islamic Azad University, Qom, Iran



The immune antigen of Bacillus anthracis is a protein that can attach to the surface receptor of all human cells. At the surface of cancer cells, there is a receptor that activates the uPA (Urokinase plasminogen) that do not exist in normal human cells.

The aim of this study was changing the location of the attachment of the PA gene by a directed mutation in order to attach only to the cancer cells.

PA gene was extracted from the pMNA1 plasmid. The mutation on the PA gene was made by Overlap Extension PCR. The mutated segment was transferred to DH5α; the strain of Escherichia coli. With TA coning carrier. By restriction enzymes Hind III and BamH I the mutated PA gene was extracted and transferred to pWB980 and by electroporation method, it was transferred to the WB600 strain.
In this study, the mutation was occurred in sequences of PA gene by SOE PCR method resulting in a change in the genetic code of amino acid 194. The occurrence of mutation was confirmed by determining base sequences.

Cancer is a severe disease that has a major impact on large groups of people which the problem of cancer is a leading cause of death across the world. One of the treatment methods of cancer is bacterial toxins if only cancer cells receive them. Therefore, these mutated PA proteins can be effective as novel therapeutic agents for the treatment of cancer.


Main Subjects

Abi-Habib, RJ, Singh, R, Liu, S, Bugge, TH, Leppla, SH, Frankel, AE. (2006). A urokinase-activated recombinant anthrax toxin is selectively cytotoxic to many human tumor cell types. Mol. Cancer Ther., 5(10):2556-2562.
Casey, JR, Petranka, JG, Kottra, J, Fleenor, DE, Rosse, WF. (1994). The structure of the urokinase-type plasminogen activator receptor gene. Blood, 84(4):1151-1156.
Cunningham, K, Lacy, DB, Mogridge, J, Collier, RJ. (2002). Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Proc. Natl. Acad. Sci. USA, 99(10):7049-7053.
Deryugina, EI, Quigley, JP. (2012). Cell surface remodeling by plasmin: a new function for an old enzyme. Bio. Med. Res. Int., 2012, Article ID 564259.
Helgason, E, Økstad, OA, Caugant, DA, Johansen, HA, Fouet, A, Mock, M, Kolstø, AB. (2000). Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis—one species on the basis of genetic evidence. Appl. Environ. Microbiol., 66(6):2627-2630.
Ivanova, N, Sorokin, A, Anderson, I, Galleron, N, Candelon, B, Kapatral, V, Bhattacharyya, A, Reznik, G, Mikhailova, N, Lapidus, A, Chu, L, Mazur, M, Goltsman, E, Larsen, N, D'Souza, M, Walunas, T, Grechkin, Y, Pusch, G, Haselkorn, R, Fonstein, M, Ehrlich, SD, Overbeek, R, Kyrpides, N. (2003). Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis. Nature, 423(6935):87-91.
Liu, S, Aaronson, H, Mitola, DJ, Leppla, SH, Bugge, TH. (2003). Potent antitumor activity of a urokinase-activated engineered anthrax toxin. Proc. Natl. Acad. Sci. USA, 100(2):657-662.
Liu, S, Bugge, TH, Frankel, AE, Leppla, SH. (2009). Dissecting the urokinase activation pathway using urokinase-activated anthrax toxin. Methods Mol. Biol., 539:175-190.
Liu, S, Schubert, RL, Bugge, TH, Leppla, SH. (2003). Anthrax toxin: structures, functions and tumour targeting. Exp. Opin Biol. Ther., 3(5):843-853.
Rogers, MS, Christensen, KA, Birsner, AE, Short, SM, Wigelsworth, DJ, Collier, RJ, D'Amato, RJ. (2007). Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth. Cancer Res., 67(20):9980-9985.
Sullivan, MA, Yasbin, RE, Young, FE. (1984). New shuttle vectors for Bacillus subtilis and Escherichia coli which allow rapid detection of inserted fragments. Gene, 29(1-2):21-26.
Wang, Y. (2001). The role and regulation of urokinase‐type plasminogen activator receptor gene expression in cancer invasion and metastasis. Med. Res. Rev., 21(2):146-170.
Wein, AN, Peters, DE, Valivullah, Z, Hoover, BJ, Tatineni, A, Ma, Q, Liu, S. (2015). An anthrax toxin variant with an improved activity in tumor targeting. Sci. Rep., 5:16267.
Zhang, J, Sud, S, Mizutani, K, Gyetko, MR, Pienta, KJ. (2011). Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model. Neoplasia (New York, NY), 13(1):23.